Injective (INJ) has now broken the 2.8 billion transaction barrier on the blockchain, a significant achievement for the network and a clear indicator of growing adoption. The announcement highlights the network’s growing adoption and robust activity.
After reaching this milestone, Injective signaled the possibility of INJ repurchases, signaling bullish intentions for investors. Analysts suggest that these moves, combined with network growth, could contribute to bullish momentum for INJ in 2026.
The rise in on-chain transactions of the platform is a testimony to its status as one of the top layer-1 protocols for decentralized finance and derivatives trading, thus it is drawing the interest of both retail and institutional investors.
Currently, INJ is trading at $3.22 with a 24-hour trading volume of $53.25 million and a market capitalization of $322.25 million. Despite the slight drop in prices by 0.20% over the past day, technical analysis indicates that INJ is poised for substantial price growth in the short term.
Also Read | VIRTUAL Tests $0.58 Support: Could It Bounce to $0.73 or Slide to $0.40?0?
Technical analysis of INJ indicates that the cryptocurrency is poised for a price retest at $11.50, a potential gain of 119%, with the next target price at $17, a gain of 225%. As a crypto analyst suggest that the RSI is near 50, while the MACD indicator is poised for a bullish crossover, an indication of balanced and improving market momentum.
Short-term price predictions for INJ indicate that the cryptocurrency will be trading at $4.72-$4.90 in one week, while medium-term predictions indicate that it will be trading at $5.80-$6.20 by February 2026, during a potential bullish breakout.
On these grounds, 2026 may prove to be a defining year for Injective, a year that brings together network adoption, development, and investor-focused initiatives to create substantial market interest.
Also Read | Cardano (ADA) Eyes $0.33 Resistance: Is a Breakout on the Horizon?
